Financials

  • Market Capitalization 5.51 B
  • Employee 106
  • Founded 2010
  • CEO Robert Barrow
  • Website www.definiumtx.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00F13HYQ7
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
1276
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
280.49 USD-1.42%-2.02%-2.53%+49.90%5.59 B USD
1279
CRSP
CRISPR Therapeutics AG - Common Shares
57.72 USD-2.78%-1.52%+21.01%+13.18%5.58 B USD
1348
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
29.11 USD-2.09%-1.32%+11.40%+12.35%5.02 B USD
1399
DYN
Dyne Therapeutics, Inc. - Common Stock
25.07 USD-3.91%-4.06%+2.33%+7.09%4.68 B USD

Definium Therapeutics, Inc. - Common Shares

Definium Therapeutics, Inc.(前身为MindMed)是一家总部位于纽约的生物技术公司,目前致力于开发迷幻药物以及更广泛意义上的心理塑形药物的临床和治疗应用。